Medical Technologies: Pharmaceutical Cosmetology, Cosmeceuticals – Opportunities and Limitations
DOI:
https://doi.org/10.5281/zenodo.18887719Keywords:
medical technologies, pharmaceutical cosmetology, cosmeceuticals, cosmeceutical active ingredients, regulatory statusAbstract
Introduction. Pharmaceutical cosmetology is an interdisciplinary field at the junction of pharmacy, dermatology, and aesthetic medicine. The active development of cosmeceuticals is associated with the growing demand for products that combine a cosmetic effect with a biological effect on the skin. At the same time, the lack of a single regulatory status and mandatory randomized clinical trials creates several scientific and legal challenges. Purpose. To analyze the possibilities and limitations of cosmeceuticals in pharmaceutical cosmetology from the standpoint of modern medical technologies, evidence-based medicine, and pharmaceutical care. Methods. A systematic literature review was conducted using the PRISMA protocol using the PubMed, Scopus, Web of Science and Cochrane Library databases for 2015–2026. Out of 1243 publications, 62 sources with evidence levels I–II according to the Oxford Centre for Evidence-Based Medicine were selected after screening. Results. The article summarizes modern technological platforms of cosmeceuticals, including nanoemulsions, liposomes, multiple emulsions, and probiotic complexes, which increase the bioavailability of active ingredients by 3-5 times. The main groups of cosmeceutical active ingredients and their clinical efficacy in photoaging, acne, hyperpigmentation and alopecia are systematized. The importance of pharmaceutical care and consulting algorithms for increasing the safety of cosmeceutical use is shown. The prospects for personalized cosmeceuticals based on genetic tests and artificial intelligence are identified. Regulatory gaps in the USA, EU and Ukraine are outlined. Conclusions. Cosmeceuticals are a promising direction of integration of pharmacy, dermatology, and digital technologies, which demonstrates proven effectiveness in mild forms of dermatoses and prevention of photoaging. Further development requires standardization of the term, development of national regulatory approaches and implementation of pharmacovigilance systems.
References
Crespi O., Rosset F., Pala V. et al. Cosmeceuticals for anti-aging: mechanisms, clinical evidence, and regulatory insights - a comprehensive review. Cosmetics. 2025. Vol.12. Iss.5. P.209. DOI: https://doi.org/10.3390/cosmetics12050209
Sivamani R., Jagdeo J., Elsner P., Maibach H. Cosmeceuticals. Drugs Cosmet Ind. 1985. Vol.136. Iss.4. P.51-52. URL: https://rudiapt.wordpress.com/wp-content/uploads/2017/11/cosmeceuticals-and-active-cosmetics-3rd-ed-2016.pdf
Kligman D. Cosmeceuticals. Dermatol Clin. 2000. Vol.18. Iss.4. P.609-615. DOI: https://doi.org/10.1016/S0733-8635(05)70211-4
Koo E., Kimball A., Wanner M. Cosmeceuticals. Wiley Online Library. 2016. DOI: https://doi.org/10.1002/9781118441213.rtd0157
El-Aziz A.A. Cosmeceuticals in Skin Aging. Cosmetics. 2025. Vol.12. Iss.5. P.209. DOI: https://doi.org/10.3390/cosmetics12050209
Cosmeceuticals Market Size, Share & Trends Analysis Report. 2023. URL: https://www.arizton.com/market-reports/cosmeceuticals-market-size-share
Newburger A.E. Cosmeceuticals: myths and misconceptions. Clin Dermatol. 2009. Vol.27. Iss.5. P.446-452. DOI: https://doi.org/10.1016/j.clindermatol.2009.05.008
FDA. Cosmeceutical. 2022. URL: https://www.fda.gov/cosmetics/cosmetics-labeling-claims/cosmeceutical
Regulation (EC) No 1223/2009 on cosmetic products. 2025. URL: http://data.europa.eu/eli/reg/2009/1223/oj
Electronic notification system for cosmetic products. URL: https://moz.gov.ua/uk/sistema-elektronnoyi-notifikaciyi-nadannya-informaciyi-pro-kosmetichnu-produkciyu
Resolution of the Cabinet of Ministers of Ukraine No. 65 On Approval of the Technical Regulations on Cosmetic Products. 2021. URL: https://zakon.rada.gov.ua/laws/show/65-2021-%D0%BF#Text
Page M.J. PRISMA 2020 explanation and elaboration. BMJ. 2021. No.372. P.n160. DOI: https://doi.org/10.1136/bmj.n160
Moher D. Preferred reporting items for systematic reviews and meta-analyses: PRISMA statement. PLoS Med. 2009. Vol.6. Iss.7. P.e1000097. DOI: https://doi.org/10.1371/journal.pmed.1000097
Oxford Centre for Evidence-Based Medicine. Levels of Evidence. 2009. URL: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009
Eccleston E., Gillian O. Functions of mixed emulsifiers and emulsifying waxes in dermatological lotions and creams. Colloids and Surfaces A. 1997. URL: https://www.academia.edu/116333169/Functions_of_mixed_emulsifiers_and_emulsifying_waxes_in_dermatological_lotions_and_creams
Aswathanarayan J., Vittal R. Nano-emulsions: their potential in food industry. Trends Food Sci Technol. 2012. Vol.28. Iss.2. P.132-144. DOI: https://doi.org/10.3389/fsufs.2019.00095
Choi S.J., McClements D.J. Nanoemulsions as delivery systems for lipophilic nutraceuticals. Food Sci Biotechnol. 2020. Vol.29. Iss.2. P.149-168. DOI: https://doi.org/10.1007/s10068-019-00731-4
Zylberberg C., Matosevic S. Pharmaceutical liposomal drug delivery. Drug Deliv. 2016. Vol.23. Iss.9. P.3319-3329. DOI: https://doi.org/10.1080/10717544.2016.1177136
ISO 22716 Cosmetics Good Manufacturing Practices. URL: https://www.iso.org/standard/36437.html
ICH Q1A(R2) Stability testing of new drug substances. 2003. URL: https://www.ema.europa.eu/en/ich-q1a-r2-stability-testing-new-drug-substances-drug-products-scientific-guideline
FDA. Modernization of Cosmetics Regulation Act (MoCRA). 2022. URL: https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra
Draelos Z.D. Cosmeceuticals: undefined, unclassified, and unregulated. Clin Dermatol. 2009. Vol.27. Iss.5. P.431–434. DOI: https://doi.org/10.1016/j.clindermatol.2009.05.005
Puizina-Ivić N. Skin aging. Acta Dermatovenerol Alp Pannonica Adriat. 2008. Vol.17. Iss.2. P.47–54. URL: https://pubmed.ncbi.nlm.nih.gov/18709289/
Mukherjee S., Date A., Patravale V. et al. Retinoids in the treatment of skin aging. Clin Interv Aging. 2006. Vol.1. Iss.4. P.327-348. DOI: https://doi.org/10.2147/ciia.2006.1.4.327
Lupo M.P., Cole A.L. Cosmeceutical peptides. Dermatol Ther. 2007. Vol.20. Iss.5. P.343–349. DOI: https://doi.org/10.1111/j.1529-8019.2007.00148.x
Pullar J.M., Carr A.C., Vissers M.M. The Roles of Vitamin C in skin health. Nutrients. 2017. Vol.9. Iss.8. P.866. DOI: https://doi.org/10.3390/nu9080866
França K. Topical Probiotics in dermatological therapy and skincare. Dermatol Ther. 2021. Vol.11. Iss.1. P.71-77. DOI: https://doi.org/10.1007/s13555-020-00476-7
Malaniuk K. Scalp microbiome as a key factor in hair growth. Annals of Mechnikov’s Institute. 2025. Iss.3. P.47-54. DOI: https://doi.org/10.5281/zenodo.17106246
Kornhauser A., Coelho S.G., Hearing V.J. Effects of cosmetic formulations containing hydroxyacids on sun-exposed skin. Dermatol Res Pract. 2012. P.710893. DOI: https://doi.org/10.1155/2012/710893
Antonara L., Triantafyllopoulou E., Chountoulesi M. et al. Lipid-based drug delivery systems. Nanomaterials. 2025. Vol.15. Iss.17. P.1326. DOI: https://doi.org/10.3390/nano15171326
Tiwari N., Osorio-Blanco E.R., Sonzogni A. et al. Nanocarriers for skin applications. Angew Chem Int Ed Engl. 2022. Vol.61. Iss.3. P.e202107960. DOI: https://doi.org/10.1002/anie.202107960
Benson H.A. Transdermal drug delivery. Curr Drug Deliv. 2005. Vol.2. Iss.1. P.23-33. DOI: https://doi.org/10.2174/1567201052772915
Plugariu I.A., Bercea M., Gradinaru L.M. New gel approaches for transdermal delivery of Meloxicam. Gels. 2025. Vol.11. Iss.7. P.500. DOI: https://doi.org/10.3390/gels11070500
Arif T. Salicylic acid as a peeling agent. Clin Cosmet Investig Dermatol. 2015. Vol.8. P.455-461. DOI: https://doi.org/10.2147/CCID.S84765
Mosca S., Morrone A. Human skin pigmentation. Healthcare. 2023. Vol.11. Iss.14. P.2091. DOI: https://doi.org/10.3390/healthcare11142091
Bylka W., Znajdek-Awiżeń P., Studzińska-Sroka E. Centella asiatica in cosmetology. Postepy Dermatol Alergol. 2013. Vol.30. Iss.1. P.46-49. DOI: https://doi.org/10.5114/pdia.2013.33378
Oxford Centre for Evidence-Based Medicine. Levels of Evidence. 2009. URL: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009
Bae B.G., Park C.O., Shin H. et al. Salicylic acid peels versus Jessner's solution for acne vulgaris. Dermatol Surg. 2013. Vol.39. Iss.2. P.248-253. DOI: https://doi.org/10.1111/dsu.12018
Camillo L., Zavattaro E., Savoia P. Nicotinamide in skin health. Medicina. 2025. Vol.61. Iss.2. P.254. DOI: https://doi.org/10.3390/medicina61020254
Hakozaki T., Minwalla L., Zhuang J. The effect of niacinamide on pigmentation. Br J Dermatol. 2002. Vol.147. Iss.1. P.20-31. DOI: https://doi.org/10.1046/j.1365-2133.2002.04834.x
Kong R., Cui Y., Fisher G. et al. Effects of retinol and retinoic acid. J Cosmet Dermatol. 2016. Vol.15. Iss.1. P.49-57. DOI: https://doi.org/10.1111/jocd.12193
Safety assessment of pentapeptides in cosmetics. 2023. URL: https://www.cir-safety.org/sites/default/files/Pentapeptides.pdf
Ruiz-Maldonado R., Tamayo-Sanchez L., Orozco-Covarrubias M.L. Retinoids in pediatric dermatology. Dermatol Clin. 1998. Vol.16. Iss.3. P.553-569. DOI: https://doi.org/10.1016/s0733-8635(05)70252-7
Akarsu S., Fetil E., Yücel F. et al. Salicylic acid with clindamycin and benzoyl peroxide. J Dermatol. 2012. Vol.39. Iss.5. P.433-438. DOI: https://doi.org/10.1111/j.1346-8138.2011.01405.x
Gupta A.K., Foley K.A. 5% Minoxidil for female pattern hair loss. Skin Therapy Lett. 2014. Vol.19. Iss.6. P.5-7. URL: https://pubmed.ncbi.nlm.nih.gov/25807073/
Mohiuddin A.K. The Excellence of Pharmacy Service. Int J Clin Dev Anat. 2019. Vol.5. Iss.2. P.11-32. DOI: https://doi.org/10.11648/j.ijcda.20190502.12
Kusynová Z., van den Ham H.A., Leufkens H.G. et al. Good Pharmacy Practice roles. J Pharm Policy Pract. 2022. Vol.15. Iss.1. P.94. DOI: https://doi.org/10.1186/s40545-022-00482-4
Juncan A.M., Moisă D.G., Santini A. et al. Hyaluronic acid in cosmeceuticals. Molecules. 2021. Vol.26. Iss.15. P.4429. DOI: https://doi.org/10.3390/molecules26154429
Navarrete-Solís J., Castanedo-Cázares J.P., Torres-Álvarez B. Niacinamide vs Hydroquinone trial. Dermatol Res Pract. 2011. P.379173. DOI: https://doi.org/10.1155/2011/379173
Fivenson D.P. Nicotinamide and zinc in inflammatory skin disease. Cutis. 2006. Vol.77. Suppl.1. P.5–10. URL: https://pubmed.ncbi.nlm.nih.gov/16871773/
Dhaliwal S., Rybak I., Ellis S.R. et al. Bakuchiol and retinol trial. Br J Dermatol. 2019. Vol.180. Iss.2. P.289-296. DOI: https://doi.org/10.1111/bjd.16918
FDA MedWatch Safety Information Program. 2026. URL: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
World Health Organization. Good Pharmacy Practice Guidelines. 2011. URL: https://www.who.int/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex8-fipwhoguidelinesgoodpharmacypractice.pdf
Lau M., Mineroff J., Wang J.Y., Jagdeo J. Cosmeceuticals for antiaging systematic review. Arch Dermatol Res. 2024. Vol.316. Iss.5. P.173. DOI: https://doi.org/10.1007/s00403-024-02908-2
Fonseca S., Amaral M.N., Reis C.P. et al. Marine natural products as cosmetic ingredients. Mar Drugs. 2023. Vol.21. Iss.3. P.170. DOI: https://doi.org/10.3390/md21030170
Haykal D., Flament F., Amar D. et al. Cosmetogenomics unveiled. Front Artif Intell. 2025. Vol.8. P.1660356. DOI: https://doi.org/10.3389/frai.2025.1660356
Markiewicz E., Idowu O.C. Personalized skincare. Clin Cosmet Investig Dermatol. 2018. Vol.11. P.161–171. DOI: https://doi.org/10.2147/CCID.S163799
Tang A.S., Wei M.L., Haemel A. et al. Artificial intelligence precision dermatology. J Invest Dermatol. 2026. DOI: https://doi.org/10.1016/j.jid.2025.10.596
Hash M.G., Forsyth A., Coleman B.A. et al. Artificial Intelligence in customized skincare. Cureus. 2025. Vol.17. Iss.4. P.e82510. DOI: https://doi.org/10.7759/cureus.82510
FDA. Is it a Cosmetic, a Drug, or Both. 2024. URL: https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap
Harmonisation status for General Texts PDG. 2025. URL: https://www.edqm.eu/en/harmonisation-status-for-general-texts-pdg
Technical document on cosmetic claims. EU Commission. 2017. URL: https://ec.europa.eu/docsroom/documents/24847
Laguna C., de la Cuadra J., Martín-González B. Allergic contact dermatitis due to cosmetics. Actas Dermosifiliogr. 2009. Vol.100. Iss.1. P.53-60. URL: https://pubmed.ncbi.nlm.nih.gov/19268112/
SCCS Opinion on Vitamin A Retinol. 2022. URL: https://health.ec.europa.eu/publications/revision-scientific-opinion-sccs157616-vitamin-retinol-retinyl-acetate-retinyl-palmitate_en
Johnson K., Kirby J., Kayse A. et al. Adherence intervention program in pharmacy. J Am Pharm Assoc. 2020. Vol.60. Iss.4. P.e70-e78. DOI: https://doi.org/10.1016/j.japh.2020.02.017
Oon H.H., Wong S.N., Aw D.C. et al. Acne management Guidelines. J Clin Aesthet Dermatol. 2019. Vol.12. Iss.7. P.34-50. URL: https://pubmed.ncbi.nlm.nih.gov/31531161/
Hochwalt A.E., Abbinante-Nissen J.M., Bohman L.C. et al. Safety assessment of tampons. Front Reprod Health. 2023. Vol.5. P.1167868. DOI: https://doi.org/10.3389/frph.2023.1167868
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Annals of Mechnikov's Institute
This work is licensed under a Creative Commons Attribution 4.0 International License.
